{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:14:02Z","timestamp":1777965242519,"version":"3.51.4"},"reference-count":29,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"publisher","award":["PCN-1-185\/N\/9\/O"],"award-info":[{"award-number":["PCN-1-185\/N\/9\/O"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Men with early-onset androgenetic alopecia are characterized by hormonal profiles similar to those observed in women with polycystic ovary syndrome. The purpose of this research was to investigate levels of cardiometabolic risk factors in 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)-treated men with early-onset androgenic alopecia. We studied two matched rosuvastatin-treated groups of men with mixed dyslipidemia: subjects with early-onset androgenic alopecia (group A) and subjects with normal hair growth (group B). Plasma lipids, glucose homeostasis markers, and levels of sex hormones, uric acid, hsCRP, homocysteine, fibrinogen, and 25-hydroxyvitamin D were measured before entering the study and six months later. Both groups differed in insulin sensitivity and levels of calculated bioavailable testosterone, dehydroepiandrosterone-sulfate, uric acid, hsCRP, fibrinogen, and 25-hydroxyvitamin D. Though observed in both study groups, treatment-induced reductions in total cholesterol, LDL cholesterol, hsCRP, and fibrinogen were more pronounced in group B than group A. Moreover, only in group A did rosuvastatin deteriorate insulin sensitivity, and only in group B did the drug affect uric acid, homocysteine, and 25-hydroxyvitamin D. The impact of rosuvastatin on cardiometabolic risk factors correlated with insulin sensitivity, calculated bioavailable testosterone, and dehydroepiandrosterone-sulfate. The obtained results suggest that men with early-onset androgenic alopecia may benefit to a lesser degree from rosuvastatin treatment than their peers.<\/jats:p>","DOI":"10.3390\/molecules26102844","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T11:30:16Z","timestamp":1620732616000},"page":"2844","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia"],"prefix":"10.3390","volume":"26","author":[{"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0674-5612","authenticated-orcid":false,"given":"Marcin","family":"Basiak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fertnstert.2017.10.018","article-title":"Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"109","author":"Yilmaz","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1007\/s00125-007-0831-9","article-title":"Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects","volume":"50","author":"Baillargeon","year":"2007","journal-title":"Diabetologia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/dc07-2190","article-title":"Metabolic phenotype in the brothers of women with polycystic ovary syndrome","volume":"31","author":"Sam","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/humrep\/dez104","article-title":"Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome","volume":"34","author":"Karthik","year":"2019","journal-title":"Hum. Reprod."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/09513590.2019.1566451","article-title":"Familial clustering of metabolic phenotype in brothers of women with polycystic ovary syndrome","volume":"35","author":"Subramaniam","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2009-1333","article-title":"High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity","volume":"94","author":"Coviello","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.fertnstert.2018.04.024","article-title":"Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"110","author":"Yilmaz","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mehy.2006.03.057","article-title":"Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited","volume":"68","author":"Kurzrock","year":"2007","journal-title":"Med. Hypotheses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mehy.2017.04.010","article-title":"Polycystic ovary syndrome in men","volume":"103","author":"Cohen","year":"2017","journal-title":"Med. Hypotheses"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","article-title":"Androgenetic alopecia: A review","volume":"57","author":"Lolli","year":"2017","journal-title":"Endocrine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40265-016-0629-5","article-title":"Androgenetic alopecia: An update of treatment options","volume":"76","author":"Kelly","year":"2016","journal-title":"Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clindermatol.2017.09.009","article-title":"Alopecia and the metabolic syndrome","volume":"36","author":"Lie","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamadermatol.2016.1776","article-title":"A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women","volume":"152","author":"Sanke","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_15","first-page":"597","article-title":"Association between androgenetic alopecia and metabolic syndrome: A meta-analysis","volume":"43","author":"Wu","year":"2014","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clindermatol.2017.09.013","article-title":"Gynecologic and andrologic dermatology and the metabolic syndrome","volume":"36","author":"Roth","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s43440-020-00135-w","article-title":"The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome","volume":"73","author":"Krysiak","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"ref_18","first-page":"330","article-title":"The effect of aggressive rosuvastatin treatment on steroid hormone production in men with coronary artery disease. Basic Clin","volume":"114","author":"Krysiak","year":"2014","journal-title":"Pharmacol. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000175841","article-title":"Laboratory measurement of testosterone","volume":"37","author":"Diver","year":"2009","journal-title":"Front. Horm. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1258\/000456306778520115","article-title":"Calculated free testosterone in men: Comparison of four equations and with free androgen index","volume":"43","author":"Ho","year":"2006","journal-title":"Ann. Clin. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000318004","article-title":"The clinical and molecular heterogeneity of 17\u03b2HSD-3 enzyme deficiency","volume":"74","author":"George","year":"2010","journal-title":"Horm. Res. Paediatr."},{"key":"ref_22","first-page":"S125","article-title":"Dehydroepiandrosterone metabolism","volume":"150","author":"Longcope","year":"1996","journal-title":"J. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2165\/00003495-200363170-00005","article-title":"Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes","volume":"63","author":"Krysiak","year":"2003","journal-title":"Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11892-017-0837-8","article-title":"Diabetes secondary to treatment with statins","volume":"17","author":"Laakso","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: From protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1747-597X-7-12","article-title":"Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA reductase","volume":"7","author":"Skogastierna","year":"2012","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1874467209666160112125631","article-title":"Interconnection of estrogen\/testosterone metabolism and mevalonate pathway in breast and prostate cancers","volume":"10","author":"Mokarram","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","article-title":"Patterned loss of hair in man; types and incidence","volume":"53","author":"Hamilton","year":"1951","journal-title":"Ann. N Y Acad Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","article-title":"Male pattern baldness: Classification and incidence","volume":"68","author":"Norwood","year":"1975","journal-title":"South. Med. J."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/10\/2844\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:59:14Z","timestamp":1760162354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/10\/2844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["molecules26102844"],"URL":"https:\/\/doi.org\/10.3390\/molecules26102844","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}